NEW YORK (GenomeWeb) – Champions Oncology announced today that it has been awarded a two-year, $2 million Small Business Innovation Research grant from the National Cancer Institute to support a project to develop and evaluate the utility of an ethnically diverse group of metastatic prostate cancer patient-derived xenograft (PDX) models.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.